Cargando…

Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia

Mycobacterium bovis bacillus Calmette–Guérin (BCG) is the only live attenuated vaccine available against tuberculosis. The first BCG vaccination was done exactly 100 years ago, in 1921. The BCG vaccine strains used worldwide represent a family of daughter sub-strains with distinct genotypic characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Panaiotov, Stefan, Hodzhev, Yordan, Tolchkov, Vladimir, Tsafarova, Borislava, Mihailov, Alexander, Stefanova, Tzvetelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000558/
https://www.ncbi.nlm.nih.gov/pubmed/33803448
http://dx.doi.org/10.3390/vaccines9030237
_version_ 1783671025713545216
author Panaiotov, Stefan
Hodzhev, Yordan
Tolchkov, Vladimir
Tsafarova, Borislava
Mihailov, Alexander
Stefanova, Tzvetelina
author_facet Panaiotov, Stefan
Hodzhev, Yordan
Tolchkov, Vladimir
Tsafarova, Borislava
Mihailov, Alexander
Stefanova, Tzvetelina
author_sort Panaiotov, Stefan
collection PubMed
description Mycobacterium bovis bacillus Calmette–Guérin (BCG) is the only live attenuated vaccine available against tuberculosis. The first BCG vaccination was done exactly 100 years ago, in 1921. The BCG vaccine strains used worldwide represent a family of daughter sub-strains with distinct genotypic characteristics. BCG SL222 Sofia is a seed lot sub-strain descending from the Russian BCG-I (seed lot 374a) strain and has been used for vaccine production in Bulgaria since 1972. Here, we report the assembled circular genome sequence of Mycobacterium bovis BCG SL222 Sofia and phylogeny analysis with the most closely related BCG sub-strains. The full circular genome of BCG SL222 Sofia had a length of 4,370,706 bp with an average GC content of 65.60%. After 49 years of in vitro evolution in a freeze-dried condition, we identified four SNP mutations as compared to the reference BCG-I (Russia-368) sequence. BCG vaccination is of central importance for the TB elimination programs in many countries. Since 1991, almost 40 million vaccine doses of the BCG SL222 Sofia have been distributed annually through the United Nations Children’s Fund (UNICEF) and the Pan American Health Organization (PAHO) to approximately 120 countries. The availability of the complete reference genome sequence for M. bovis BCG SL222 Sofia, a WHO reference reagent for the Russian BCG-I sub-strain, will facilitate the identity assurance of the genomic stability, will contribute to more consistent manufacturing, and has an important value in standardization and differentiation of sub-strains used in vaccine production. We propose to rename the sub-strain BCG SL222 Sofia to BCG-Sofia for practical and common use.
format Online
Article
Text
id pubmed-8000558
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80005582021-03-28 Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia Panaiotov, Stefan Hodzhev, Yordan Tolchkov, Vladimir Tsafarova, Borislava Mihailov, Alexander Stefanova, Tzvetelina Vaccines (Basel) Article Mycobacterium bovis bacillus Calmette–Guérin (BCG) is the only live attenuated vaccine available against tuberculosis. The first BCG vaccination was done exactly 100 years ago, in 1921. The BCG vaccine strains used worldwide represent a family of daughter sub-strains with distinct genotypic characteristics. BCG SL222 Sofia is a seed lot sub-strain descending from the Russian BCG-I (seed lot 374a) strain and has been used for vaccine production in Bulgaria since 1972. Here, we report the assembled circular genome sequence of Mycobacterium bovis BCG SL222 Sofia and phylogeny analysis with the most closely related BCG sub-strains. The full circular genome of BCG SL222 Sofia had a length of 4,370,706 bp with an average GC content of 65.60%. After 49 years of in vitro evolution in a freeze-dried condition, we identified four SNP mutations as compared to the reference BCG-I (Russia-368) sequence. BCG vaccination is of central importance for the TB elimination programs in many countries. Since 1991, almost 40 million vaccine doses of the BCG SL222 Sofia have been distributed annually through the United Nations Children’s Fund (UNICEF) and the Pan American Health Organization (PAHO) to approximately 120 countries. The availability of the complete reference genome sequence for M. bovis BCG SL222 Sofia, a WHO reference reagent for the Russian BCG-I sub-strain, will facilitate the identity assurance of the genomic stability, will contribute to more consistent manufacturing, and has an important value in standardization and differentiation of sub-strains used in vaccine production. We propose to rename the sub-strain BCG SL222 Sofia to BCG-Sofia for practical and common use. MDPI 2021-03-09 /pmc/articles/PMC8000558/ /pubmed/33803448 http://dx.doi.org/10.3390/vaccines9030237 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Panaiotov, Stefan
Hodzhev, Yordan
Tolchkov, Vladimir
Tsafarova, Borislava
Mihailov, Alexander
Stefanova, Tzvetelina
Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia
title Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia
title_full Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia
title_fullStr Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia
title_full_unstemmed Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia
title_short Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain Mycobacterium bovis BCG SL222 Sofia
title_sort complete genome sequence, genome stability and phylogeny of the vaccine strain mycobacterium bovis bcg sl222 sofia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000558/
https://www.ncbi.nlm.nih.gov/pubmed/33803448
http://dx.doi.org/10.3390/vaccines9030237
work_keys_str_mv AT panaiotovstefan completegenomesequencegenomestabilityandphylogenyofthevaccinestrainmycobacteriumbovisbcgsl222sofia
AT hodzhevyordan completegenomesequencegenomestabilityandphylogenyofthevaccinestrainmycobacteriumbovisbcgsl222sofia
AT tolchkovvladimir completegenomesequencegenomestabilityandphylogenyofthevaccinestrainmycobacteriumbovisbcgsl222sofia
AT tsafarovaborislava completegenomesequencegenomestabilityandphylogenyofthevaccinestrainmycobacteriumbovisbcgsl222sofia
AT mihailovalexander completegenomesequencegenomestabilityandphylogenyofthevaccinestrainmycobacteriumbovisbcgsl222sofia
AT stefanovatzvetelina completegenomesequencegenomestabilityandphylogenyofthevaccinestrainmycobacteriumbovisbcgsl222sofia